Anika Therapeutics
ANIK
$27.36
Share price
3.28%
Change (1 day)
5.23%
Change (1 year)
Categories
Anika Therapeutics (ANIK) - Total debt
Total debt on the balance sheet as of December 2023 : $29.03 M
According to Anika Therapeutics's latest financial reports the company's total debt is $29.03 M. A company’s total debt is the sum of all current and non-current debts.
Anika Therapeutics - Total debt on balance sheet (from 2008 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $30.89 M | 47.42% |
| 2021-12-31 | $20.95 M | -6.72% |
| 2020-12-31 | $22.46 M | -0.2% |
| 2019-12-31 | $22.5 M | |
| 2018-12-31 | $N/A | |
| 2012-12-31 | $9.6 M | -14.29% |
| 2011-12-31 | $11.2 M | -12.5% |
| 2010-12-31 | $12.8 M | -11.11% |
| 2009-12-31 | $14.4 M | -10% |
| 2008-12-31 | $16 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 100,915.95% | 🇺🇸 USA |
 Medtronic MDT | $25.18 B | 86,623.84% | 🇮🇪 Ireland |
 Stryker Corporation SYK | $12.99 B | 44,653.25% | 🇺🇸 USA |
 STAAR Surgical STAA | $35.83 M | 23.41% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $1.49 B | 5,063.24% | 🇺🇸 USA |
 Hill-Rom HRC | N/A | N/A | 🇺🇸 USA |